Scientists at City of Hope have uncovered a gene called SMOC1 that plays a surprising role in the development of type 2 ...
For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon raises it. But that’s much too simple, new research says. Scientists at Duke ...
AHAs, like glycolic acid, are water-soluble and work on the surface of the skin. Using these ingredients gently sheds dead ...
Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
In early September, Alpha Tau announced that it treated the first patient in its 30-patient US trial. This trial is set to ...
Scientists at City of Hope® have uncovered a gene called SMOC1 that plays a surprising role in the development of type 2 ...
News-Medical.Net on MSN
SMOC1 gene plays a surprising role in the development of type 2 diabetes
Scientists at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S., and ...
Bel Group and Standing Ovation achieve industrial-scale production of casein proteins from whey using precision fermentation, ...
A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation — and pointing to a surprising new ally in the fight against type 2 diabetes. Published ...
ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine ...
About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback